These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 20937539)
1. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Pan X; Cao H; Lu J; Shu X; Xiong X; Hong X; Xu Q; Zhu H; Li G; Shen G Mol Immunol; 2011 Jul; 48(12-13):1573-7. PubMed ID: 21481941 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. Zhang F; Wang Q; Ye L; Feng Y; Zhang X J Med Virol; 2010 May; 82(6):920-8. PubMed ID: 20419804 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells. Huang WC; Chen WS; Chen YJ; Wang LY; Hsu SC; Chen CC; Hung MC J Cell Physiol; 2012 Apr; 227(4):1446-54. PubMed ID: 21618535 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-κB pathway. Xia L; Tian D; Huang W; Zhu H; Wang J; Zhang Y; Hu H; Nie Y; Fan D; Wu K J Immunol; 2012 Jan; 188(2):753-64. PubMed ID: 22174449 [TBL] [Abstract][Full Text] [Related]
7. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism]. Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631 [TBL] [Abstract][Full Text] [Related]
8. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector]. Joo HY; Han KH; Ryu WS Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325 [TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling. Shukla R; Yue J; Siouda M; Gheit T; Hantz O; Merle P; Zoulim F; Krutovskikh V; Tommasino M; Sylla BS Carcinogenesis; 2011 Jul; 32(7):978-85. PubMed ID: 21459755 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY; Kim JK; Kim HJ; Ahn JK IUBMB Life; 2005 Sep; 57(9):651-8. PubMed ID: 16203685 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Shan C; Zhang S; Cui W; You X; Kong G; Du Y; Qiu L; Ye L; Zhang X Carcinogenesis; 2011 Aug; 32(8):1190-7. PubMed ID: 21665888 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. Lee MO; Choi YH; Shin EC; Kang HJ; Kim YM; Jeong SY; Seong JK; Yu DY; Cho H; Park JH; Kim SJ J Hepatol; 2002 Sep; 37(3):380-6. PubMed ID: 12175634 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. Quétier I; Brezillon N; Duriez M; Massinet H; Giang E; Ahodantin J; Lamant C; Brunelle MN; Soussan P; Kremsdorf D J Hepatol; 2013 Aug; 59(2):285-91. PubMed ID: 23542345 [TBL] [Abstract][Full Text] [Related]
15. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368 [TBL] [Abstract][Full Text] [Related]
16. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183 [TBL] [Abstract][Full Text] [Related]
18. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [TBL] [Abstract][Full Text] [Related]
19. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. Wang Y; Lu Y; Toh ST; Sung WK; Tan P; Chow P; Chung AY; Jooi LL; Lee CG J Hepatol; 2010 Jul; 53(1):57-66. PubMed ID: 20447714 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]